References
- Shane R. Risk evaluation and mitigation strategies: impact on patients, health care providers, and health systems. Am J Health Syst Pharm. 2009; 66(24 Suppl 7): S6–S12.
- Mason LJ. The FDA Drug Safety Communication: what Does This Mean About Anesthesia Safety for Mothers and Children? ASA Monitor 2018;81: 6–8.
- Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164(9):1356–1363.
- Furedi A. The public health implications of the 1995 ‘pill scare’. Hum Reprod Update. 1999;5(6):621–626.
- Wood R, Botting B, Dunnell K. Trends in conceptions before and after the 1995 pill scare. Popul Trends. 1997;(89):5–12.
- Goldman SA. Communication of medical product risk: how effective is effective enough? Drug Saf. 2004;27(8):519–534.
- Marcum ZA, Vande Griend JP, Linnebur SA. FDA drug safety communications: a narrative review and clinical considerations for older adults. Am J Geriatr Pharmacother. 2012;10(4):264–271.
- CDER’s Drug Safety Communications: Ensuring postmarket safety. [cited 2024 Feb 20]. Available from: https://www.fda.gov/drugs/news-events-human-drugs/cders-drug-safety-communications-ensuring-postmarket-safety.
- Kesselheim AS, Sinha MS, Campbell EG, et al. Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem. Drug Saf. 2019;42(11):1287–1295.
- Kesselheim AS, Sinha MS, Rausch P, et al. Patients’ Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: a National Survey. J Law Med Ethics. 2019;47(3):430–441.
- Department of Health and Human Services. medication guides for Prescription Drug Products. Title 21 Code of Federal Regulations. Pt. 208. 2004:115–116.
- Stevenson FA, Cox K, Britten N, et al. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004;7(3):235–245.
- Wolf MS, King J, Wilson EA, et al. Usability of FDA-approved medication guides. J Gen Intern Med. 2012;27(12):1714–1720.
- Wolf MS, Davis TC, Shrank WH, et al. A critical review of FDA-approved Medication Guides. Patient Educ Couns. 2006;62(3):316–322.
- Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015; 2015:217047.
- Kim J, Combs K, Downs J, et al. Medication adherence: The elephant in the room. US Pharm. 2018;43:30–34.
- Benjamens S, Dhunnoo P, Görög M, et al. Forecasting artificial intelligence trends in health care: systematic international patent analysis. JMIR AI. 2023;2:e47283.
- Benjamens S, Dhunnoo P, Meskó B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med. 2020;3:118.
- Zaretsky J, Kim JM, Baskharoun S, et al. Generative Artificial Intelligence to Transform Inpatient Discharge Summaries to Patient-Friendly Language and Format. JAMA Netw Open. 2024;7(3):e240357.
- Cascella M, Semeraro F, Montomoli J, et al. The Breakthrough of Large Language Models Release for Medical Applications: 1-Year Timeline and Perspectives. J Med Syst. 2024;48(1):22.
- Clusmann J, Kolbinger FR, Muti HS, Carrero ZI, Eckardt JN, Laleh NG, Löffler CML, Schwarzkopf SC, Unger M, Veldhuizen GP, Wagner SJ, Kather JN. The future landscape of large language models in medicine. Commun Med (Lond). 2023;3(1):141.
- Meskó B. The Impact of Multimodal Large Language Models on Health Care’s Future. J Med Internet Res. 2023;25:e52865.
- Moons P, Van Bulck L. Using ChatGPT and Google Bard to improve the readability of written patient information: A proof-of-concept. Eur J Cardiovasc Nurs. 2023: zvad087.
- ChatGPT 4.0. [cited 2024 Feb 17]. Available from: https://chat.openai.com/ (Accessed on 17th February, 2024).
- Google Gemini. [cited 2024 Feb 17]. Available from: https://gemini.google.com/app
- Drug Safety Communications. [cited 2024 Feb 16]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/drug-safety-communications
- US FDA Medication Guides. [cited 2024 Feb 17]. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=medguide.page&utm_campaign=SBIA%3A%20FDA%20Launches%20New%20Medication%20Guide%20Database&utm_medium=email&utm_source=Eloqua
- Centers for Disease Control and Prevention. Simply put: a guide for creating easy-to-understand materials. In. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
- Hutchinson N, Baird GL, Garg M. Examining the Reading Level of Internet Medical Information for Common Internal Medicine Diagnoses. Am J Med. 2016;129(6): 637–639.
- Lipovetsky S. Readability Indices Structure and Optimal Features. Axioms. 2023;12(5):421. doi: 10.3390/axioms12050421
- Readable. [cited 2024 Feb 18]. Available from: https://readable.com/
- Davis TC, Wolf MS, Bass PF 3rd, et al. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006;21(8):847–51.
- FDA’s external communications. Available at: https://www.fda.gov/media/100885/download (Accessed on 20th February 2024).
- Bahri P, Bowring G, Edwards BD, et al. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance. Drug Saf. 2023;46(6):517–532.
- Santana S, Brach C, Harris L, et al. Updating Health Literacy for Healthy People 2030: Defining Its Importance for a New Decade in Public Health. J Public Health Manag Pract. 2021;27(Suppl 6): S258–S264.
- Bakdash L, Abid A, Gourisankar A, et al. Chatting Beyond ChatGPT: Advancing Equity Through AI-Driven Language Interpretation. J Gen Intern Med. 2023 Oct 30. doi: 10.1007/s11606-023-08497-6.
- Ayre J, Mac O, McCaffery K, et al. New Frontiers in Health Literacy: Using ChatGPT to Simplify Health Information for People in the Community. J Gen Intern Med. 2023. doi: 10.1007/s11606-023-08469-w.
- Medication Guides: Patient Medication Information. A Proposed Rule by the Food and Drug Administration on 05/31/2023. [cited 2024 Feb 18]. Available from: https://www.federalregister.gov/documents/2023/05/31/2023-11354/medication-guides-patient-medication-information
- Koch-Weser S, Rudd RE, Dejong W. Quantifying word use to study health literacy in doctor-patient communication. J Health Commun. 2010;15(6):590–602.